Nobleza, Bb Girl .
HRN: 24-25-12 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2023
AMPICILLIN 250MG (VIAL)
12/16/2023
12/22/2023
IV
130mg
Q12h
Potentially Septic Newborn
Checking Final Appropriateness
12/16/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/16/2023
12/22/2023
IV
39mg
OD
Potentially Septic Newborn
Checking Final Appropriateness